Feedback / Questions
Xospata (gilteritinib) - Astellas
Xospata: Primary analysis data readout from P3 PASHA trial (NCT04027309) for newly diagnosed AML in H1 FY2026
(Astellas)
-
Apr 27, 2025 -
FY 2024 Results
P3 data
•
Acute Myelogenous Leukemia • Hematological Malignancies • Oncology
https://www.astellas.com/en/system/files/534ea626b9/4q2024_pre_en.pdf
Apr 27, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious